Derek M Meisner insider trades

Open-market stock purchases and sales by Derek M Meisner, Chief Legal Officer & Corp Sec at Acumen Pharmaceuticals, Inc, from SEC Form 4 filings since Sep 20, 2018.

Recent trades

DateStockTradeValue
Mar 6, 2026ABOS Acumen Pharmaceuticals, IncSold$6.8K
Mar 6, 2026ABOS Acumen Pharmaceuticals, IncBought (not open market)—
Feb 27, 2026ABOS Acumen Pharmaceuticals, IncSold$28.3K
Feb 27, 2026ABOS Acumen Pharmaceuticals, IncBought (not open market)—
Jan 28, 2026ABOS Acumen Pharmaceuticals, IncSold$8K
Jan 28, 2026ABOS Acumen Pharmaceuticals, IncBought (not open market)—
Jan 26, 2026ABOS Acumen Pharmaceuticals, IncSold$45.3K
Jan 26, 2026ABOS Acumen Pharmaceuticals, IncBought (not open market)—
Jan 23, 2026ABOS Acumen Pharmaceuticals, IncSold$10.7K
Jan 22, 2026ABOS Acumen Pharmaceuticals, IncSold$1.9K
Jan 21, 2026ABOS Acumen Pharmaceuticals, IncSold$4.1K
Jan 16, 2026ABOS Acumen Pharmaceuticals, IncBought (not open market)—
Jan 16, 2026ABOS Acumen Pharmaceuticals, IncBought (not open market)—
Jan 12, 2026ABOS Acumen Pharmaceuticals, IncSold$14.7K
Jan 9, 2026ABOS Acumen Pharmaceuticals, IncSold$9.2K
Jan 8, 2026ABOS Acumen Pharmaceuticals, IncSold$12.4K
Jan 8, 2026ABOS Acumen Pharmaceuticals, IncSold$54.9K
Jan 7, 2026ABOS Acumen Pharmaceuticals, IncSold$3.4K
Jan 7, 2026ABOS Acumen Pharmaceuticals, IncSold$20K
Jan 6, 2026ABOS Acumen Pharmaceuticals, IncSold$14K
Jan 6, 2026ABOS Acumen Pharmaceuticals, IncSold$7.5K
Jan 5, 2026ABOS Acumen Pharmaceuticals, IncSold$7.8K

Companies traded

  • ABOS Acumen Pharmaceuticals, Inc: 19 sales, last Mar 6, 2026
  • XFOR X4 Pharmaceuticals, Inc: 8 sales, last Aug 17, 2022
  • GNCA Genocea Biosciences, Inc: other filings, last Sep 20, 2018

Get free alerts when Derek M Meisner files a new trade →